Rivastigmine as an early treatment for visual hallucinations in Parkinson’s disease (CHEVAL)
Cholinesterase inhibitors to slow progression of visual hallucinations in Parkinson’s disease: a multi-center placebo-controlled trial (CHEVAL) - CHEVAL Cholinesterase inhibitors to slow progression of visual hallucinations in Parkinson’s disease: a mul ...
Parkinson's disease MedDRA version: 18.0;Level: PT;Classification code 10061536;Term: Parkinson's disease;System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] Parkinson's disease MedDRA version: 18.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...
Trade Name: Rivastigmine CF
VU University Medical Center
NULL
Not Recruiting
Female: yes Male: yes
168
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): yes Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...